CytomX Therapeutics, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Dec 2012 | — | $-26.0M | $14.7M |
| Dec 2013 | — | $-44.3M | $8.7M |
| Sep 2014 | — | — | $53.3M |
| Dec 2014 | $1.6M | $-78.5M | $64.4M |
| Mar 2015 | — | — | $7.8M |
| Jun 2015 | — | — | $45.8M |
| Sep 2015 | — | $-106.0M | $36.2M |
| Dec 2015 | — | $126.1M | $59.8M |
| Mar 2016 | — | $112.7M | $67.9M |
| Jun 2016 | — | $101.2M | $62.4M |
| Sep 2016 | — | $89.4M | $59.8M |
| Dec 2016 | — | $78.5M | $104.6M |
| Mar 2017 | — | $73.8M | $85.7M |
| Jun 2017 | — | $52.2M | $272.9M |
| Sep 2017 | — | $45.5M | $284.2M |
| Dec 2017 | — | $69.9M | $177.5M |
| Mar 2018 | — | $49.6M | $142.2M |
| Jun 2018 | — | $41.1M | $132.9M |
| Sep 2018 | — | $157.7M | $259.8M |
| Dec 2018 | — | $135.8M | $247.6M |
| Mar 2019 | — | $122.6M | $190.4M |
| Jun 2019 | — | $101.5M | $149.4M |
| Sep 2019 | — | $82.1M | $164.6M |
| Dec 2019 | — | $25.5M | $188.4M |
| Mar 2020 | — | $69.8M | $143.3M |
| Jun 2020 | — | $58.8M | $291.4M |
| Sep 2020 | — | $48.1M | $176.8M |
| Dec 2020 | — | $-7.8M | $191.9M |
| Mar 2021 | — | $80.7M | $329.7M |
| Jun 2021 | — | $58.1M | $256.1M |
| Sep 2021 | — | $30.4M | $236.3M |
| Dec 2021 | — | $-459.0K | $205.5M |
| Mar 2022 | — | $-29.7M | $163.5M |
| Jun 2022 | — | $-54.5M | $129.3M |
| Sep 2022 | — | $-80.5M | $95.0M |
| Dec 2022 | — | $-85.8M | $193.7M |
| Mar 2023 | — | $-86.6M | $56.4M |
| Jun 2023 | — | $-85.0M | $57.5M |
| Sep 2023 | — | $-51.2M | $26.0M |
| Dec 2023 | — | $-47.4M | $17.2M |
| Mar 2024 | — | $-31.7M | $36.2M |
| Jun 2024 | — | $-31.2M | $43.2M |
| Sep 2024 | — | $-23.5M | $40.6M |
| Dec 2024 | — | $-456.0K | $38.1M |
| Mar 2025 | — | $25.0M | $47.6M |
| Jun 2025 | — | $119.9M | $49.0M |
| Sep 2025 | — | $107.4M | $34.2M |
| Dec 2025 | — | $99.0M | $12.7M |
| Mar 2026 | — | $319.9M | $28.8M |
| Jun 2026 | — | $302.1M | $17.2M |